Emergent BioSolutions Inc. Net Income Loss

• Emergent BioSolutions Inc. showed an increase of +74.9% in Net Income Loss from 2023 to 2024.
• This data is from Emergent BioSolutions Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2025.
• XBRL data for this metric is available from 2009 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2009 to 2024), Emergent BioSolutions Inc.'s Net Income Loss has declined by 712.0%.
• Historical annual values: Fiscal year 2024: -$190.60 million | Fiscal year 2023: -$760.50 million | Fiscal year 2022: -$211.60 million | Fiscal year 2021: $219.50 million | Fiscal year 2020: $305.10 million | Fiscal year 2019: $54.50 million | Fiscal year 2018: $62.70 million | Fiscal year 2017: $82.60 million | Fiscal year 2016: $51.80 million | Fiscal year 2015: $62.87 million | Fiscal year 2014: $36.74 million | Fiscal year 2013: $31.14 million | Fiscal year 2012: $23.52 million | Fiscal year 2011: $23.02 million | Fiscal year 2010: $51.70 million | Fiscal year 2009: $31.14 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026